Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.66 USD | -1.33% |
|
-9.57% | +163.75% |
06-28 | Novavax: ACIP in favor of Covid 24/25 vaccine | CF |
06-27 | US CDC advisers recommend updated COVID vaccines for those six months and older | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+163.75% | 1.8B | |
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Novavax Seeks EU Authorization for Updated Covid-19 Vaccine